Medical Ozone Therapy Market Growth Accelerated by Adoption of Multifunctional Devices
Medical ozone therapy is widely used in alternative medicine for its strong biological effects. Ozone therapy can enhance the blood circulation and oxygen delivery to tissues and cells to alleviate symptoms associated with various medical conditions such as ischemic conditions. The global Medical Ozone Therapy Market is estimated to be valued at US$ 1.59 Bn in 2024 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends: Adoption of multifunctional ozone therapy devices is
expected to drive the market growth over the forecast period. These devices
offer multiple functionalities such as automatic gas control, automatic process
control, and automatic dose control. For instance, the APOZAMPRO device offered
by Kastner PPM GmbH allows automatic control of the ozone dosage and enables
treatment of large body areas. Increasing preference for these advanced
multifunctional devices over conventional standalone devices among end users is
anticipated to fuel the medical ozone therapy market growth during the forecast
period.
Segment Analysis
Medical
ozone therapy market is dominated by major application sub segment
therapeutics. Therapeutics segment accounts for over 60% market share due to
wide usage of ozone therapy in treatment of musculoskeletal disorders, herniated
discs, and chronic wounds. Diseases like lower back pains, joint pains are
commonly treated with ozone therapy which drives the growth of this sub
segment.
Key Takeaways
The global medical ozone therapy market is expected to witness high growth over
the forecast period of 2023 to 2030.
Key players operating in the medical ozone therapy market are Kastner-Praxisbedarf GmbH, Herrmann Apparatebau GmbH, Zotzmann + Stahl GmbH + Co. KG, Ozonline, HANKEY ASIA CO., LTD., Elatec GmbH, Dr. Hänsler Ozonosan, Promolife. These players are focusing on new product launches and mergers & acquisitions to strengthen their foothold in the market. For instance, in 2021, Zotzman + Stahl GmbH opened a new production facility in Italy to expand its medical ozone generator portfolio and manufacturing capabilities in Europe.

Comments
Post a Comment